Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Merrimack Pharmaceuticals Inc (MACK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2012	09-2012	06-2012	03-2012	12-2011
Assets
Current Assets
Cash & Cash Equivalents	37,814	28,009	32,143	30,655	50,454
Marketable Securities	72,238	58,759	74,669	N/A	N/A
Receivables	9,267	6,054	6,940	5,980	7,426
Other current assets	0	0	0	2,631	1,946
TOTAL	$128,301	$104,081	$120,322	$45,792	$65,589

Non-Current Assets
PPE Net	6,297	4,834	5,040	5,232	6,206
Intangibles	12,780	12,860	12,940	13,020	13,100
Other Non-Current Assets	1,596	1,436	404	404	404
TOTAL	$20,673	$19,130	$18,384	$18,656	$19,710

Total Assets	$148,974	$123,211	$138,706	$64,448	$85,299

Liabilities
Current Liabilities
Short Term Debt	2,373	N/A	N/A	N/A	N/A
Accounts payable and accrued liabilities	25,644	771	2,745	2,599	17,511
Accrued Expenses	N/A	16,759	14,113	13,061	N/A
Other current liabilities	1,153	1,295	115	135	125
TOTAL	$38,520	$28,189	$26,672	$24,805	$26,151

Non-Current Liabilities
Long Term Debt	37,482	N/A	N/A	N/A	N/A
Deferred Revenues	9,350	8,764	8,562	8,245	7,712
Other Non-Current Liabilities	7,745	6,261	315	1,306	1,644
TOTAL	$116,971	$82,003	$78,949	$83,249	$80,839

Total Liabilities	$155,491	$110,192	$105,621	$108,054	$106,990

Shareholders' Equity
Shares Outstanding, K	9,590	9,418	9,372	9,330	N/A
Common Shares	958	940	935	119	118
Retained earnings	-442,116	-417,348	-394,149	-374,123	-350,839
Other shareholders' equity	-38	232	294	268,681	268,799
TOTAL	$-6,517	$13,019	$33,085	$-43,606	$-21,691

Total Liabilities And Equity	$148,974	$123,211	$138,706	$64,448	$85,299